Abstract
Fifty cases of infantile plyoric stenosis were treated conservatively by transpyloric nasoduodenal tube feeding.
The mean age on admission was 38.2 days. Transpyloric intubation was carried out in all patients and 45 (90%) with infantile pyloric stenosis were cured by nasoduodenal feeding. Among 5 (10%) requiring surgical intervention, abandonment of nasoduodenal feeding was the cause in only 3, and the parents chose an operation in the remaining 2 a few days after nasoduodenal feeding had been started. In non-surgically cured cases (45), mean body weights on admission and at discharge were 3,750 g and 5,177 g respectively; the duration of nasoduodenal feeding was 8 to 37 days (mean 17.2 days), mean weight gain during nasoduodenal feeding was 42.7 g/day and mean hospital stay was 39.7 days (38.0 days in 43 cases without any associated disorder).
This experience suggests that nasoduodenal feeding in this report is a more effective treatment for infantile pyloric stenosis than any traditional medical treatment and it could be the preferred management in the small group of patients for whom an operation could carry a high risk, or whose parents refuse operation.
Similar content being viewed by others
References
Bøggild-Madsen NB (1975) Medicinsk behandlung af kongenit pylorusstenose. En oversigt behandlingen pa et centralsygehus. Ugeskr Laeg 137: 201–203
Coroner BD (1955) Hypertrophic pyloric stenosis in infancy treated with methyl scopolamine nitrate. Arch Dis Child 30: 377–386
Day LR (1969) Medical management of pyloric stenosis. JAMA 207: 948–950
Dodge JA, Karim AA (1976) Induction of pyloric hypertrophy by pentagastrin. Gut 17: 280–284
Eschenbacher HL, Göbel H (1972) Zur Behandlung der spastisch-hypertrophischen Pylorusstenose mit Methylscopolaminitrat. Klin Päd 184: 367–371
Jacoby NM (1962) Pyloric stenosis: Selective medical treatment. A survey of 16 years experience. Lancet 1: 119–121
Malmberg N (1949) Hypertrophic pyloric stenosis — A survey of 136 successive cases with special reference to treatment with scpoyl. Acta Paediat 38: 472–483
Mellin GW, Santulli T, Altman HS (1965) Congenital pyloric stenosis: A controlled evaluation of medical treatment utilizing methyl-scopolamine. J Pediatr 66: 649–657
Rayford PL, Miller TA, Thompson JC (1976) Secretin, Cholecystokinin and newer gastrointestinal hormones. N Engl J Med 294: 1093–1101
Rhea JW, Kilby JO (1970) A nasojejunal tube for infant feeding. Pediatrics 46: 36–40
Schäfer KH, Bingel G (1975) Konservative und chirurgische Therapie der spastischen, hypertrophischen Pylorusstenose (s.h.P.). Eine katamnestische Studie. Mschr Kinderheilk 123: 503–508
Shandling B (1979) Congenital hypertrophic pyloric stenosis. In: Vaugham VC III, Mckay RC Jr, Behrman RE (eds) Textbook of Pediatrics. W.B. Saunders Company, Philadelphia, pp 1050–1053
Yamashiro Y, Mayama H, Yamamoto K, Nawate G, Kato H (1977) Serum gastrin levels and G cell in the antral mucosa in congenital hypertrophic pyloric stenosis. Abstracts of papers XV International Congress of Pediatrics, New Delhi, India, p 51
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamashiro, Y., Mayama, H., Yamamoto, K. et al. Conservative management of infantile pyloric stenosis by nasoduodenal feeding. Eur J Pediatr 136, 187–192 (1981). https://doi.org/10.1007/BF00441922
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00441922